Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunshan Oriental Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing enterprise based in Kunshan, China, and operates as a wholly-owned subsidiary of China Resources Double-Crane Pharmaceutical. The company specializes in the production of chemical drugs and traditional Chinese medicines, with a core focus on endocrinology and respiratory health. Its portfolio includes widely distributed treatments for type 2 diabetes, such as Metformin and Gliclazide, as well as over-the-counter cold and flu medications. The company maintains large-scale, GMP-certified manufacturing facilities for various oral dosage forms, including tablets, capsules, and granules. As part of the China Resources Pharmaceutical Group, it serves as a key production base for the group's generic drug and TCM commercialization efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunshan Oriental Pharmaceutical.